OnLume presenting at SPIE:BiOS

Join our talk presented by our collaborator at the SPIE BiOS:Molecular-Guided Surgery Conference on Sunday, Feb 2 @ 12:10 PM: “A proof-of-concept methodology to validate the in situ visualization of residual disease using cancer-targeted molecular agents in fluorescence-guided surgery.”

For more information, view our abstract on the Molecular-Guided Surgery conference website.